In vitro susceptibilities of Rickettsia rickettsii and Rickettsia conorii to roxithromycin, pristinamycin, and the pristinamycin compounds, P1 and P2, were determined by a dye uptake assay and a plaque assay. The MICs were 1 ,Ig/ml for roxithromycin, 2 ,Lg/ml for pristinamycin, >256 ,ug/ml for P1, and 2 ,ug/ml for P2. Compounds P1 and P2 did not share synergetic activity. The toxicity of each compound was determined by a dye uptake assay. Toxic concentrations were 128 ,ug/ml for roxithromycin, 32 ,ug/ml for pristinamycin, >256
Mountain spotted fever and Mediterranean spotted fever.
Rickettsia rickettsii and Rickettsia conorii are obligate intracellular bacteria. Their morphological characteristics and biochemical compositions are similar to those of gramnegative bacteria. Antibiotics active against these rickettsial species must penetrate intracellularly. Both rickettsial species are susceptible in vitro to the following antibiotics: tetracycline, chloramphenicol, and rifampin (10) ; pefloxacin (9) ; ofloxacin (D. Raoult, M. Yeaman, and 0. Baca, Rev. Infect. Dis., in press); and ciprofloxacin (7) .
R. rickettsii is the etiological agent of Rocky Mountain spotted fever (RMSF), and R. conorii is the etiological agent of Mediterranean spotted fever (MSF). The recommended treatment for both diseases is tetracycline or chloramphenicol (2, 3) . These two antibiotics are toxic during pregnancy and childhood and should not be used in these situations. In such cases, macrolide antibiotics are proposed as alternative therapy, but the susceptibilities of rickettsiae to these compounds are highly variable.
We present the results of in vitro tests of the susceptibilities of R. rickettsii and R. conorii to the macrolide antibiotic roxithromycin and to the streptogramin antibiotic pristinamycin and its compounds, P1 and P2 (4).
Bacterial strains. R. rickettsii (Sheila Smith strain) and R. conorii (Moroccan strain) were cultivated on Vero cells. The titer of the inoculum was determined by plaque assay (12) and adjusted to in each well of the first line, 200 PFU per well was added in the second line, and 20 PFU per well was added in the third line. The fourth line was used as a cell control, and no rickettsiae were added. Two thousand PFU of rickettsiae was added in each well of the eight remaining lines, which were then used for antibiotic assay. Antibiotic was dispensed in a volume of 50 ,ul per well. Eight serial dilutions from 64 to 0.5 ,ug/ml were tested. Additional dilutions were tested if necessary. The plate was then incubated for 4 days at 36°C in a 5% CO2 incubator. The medium was then discarded, and 50 ,ul of neutral red dye (0.15% in saline, pH 5.5) was placed in each well. The plate was incubated for 1 h at 36°C. The wells were washed three times with phosphate-buffered saline, and the incorporated red dye was extracted by using 100 ,u of phosphate ethanol buffer (10% ethanol in phosphate-buffered saline, pH 4.2) per well.
The optical density at 492 nm (OD492) of the solution was determined with a spectrophotometer (Flow Laboratories, McLean, Va.). A concentration of antibiotic was estimated as efficient if the mean OD492 of the line was between those of the cell control line and the line with 20 PFU per well.
(ii) Plaque assay. Five milliliters of a suspension of 1.5 x 104 Vero cells per ml was dispensed in each tissue culture petri dish (diameter, 60 mm; Corning Glass Works, Coming, N.Y.). Dishes were incubated for 24 h at 36°C in a 5% CO2 incubator. The medium was then discarded, and the confluent cell monolayers were inoculated with 1 ml of a solution containing 4 x 104 PFU of rickettsiae. After incubation for 1 h at 22°C, infected cells were overlaid with 5 ml of a medium containing MEM, 2% fetal calf serum, and 0.5% agar. Antibiotics were added to a final concentration of 0 (positive control), 0.5, 1, 2, and 4 ,ug/ml. Additional dilutions were tested if necessary. The dishes were incubated for 4 days at 36°C in a 5% CO2 incubator and were then stained by adding a second overlay containing MEM, 0.5% agar, and 0.01% neutral red dye. Three experiments were carried out at each antibiotic concentration.
Toxicity tests. The toxicity of each antibiotic for Vero cells was determined by using a dye uptake assay similar to that described above. A suspension of 1.5 x 104 Vero cells per ml in a solution of MEM, 5% fetal calf serum, and 2 mM glutamine was prepared. One hundred microliters of the suspension was dispensed in each well of a 96-well, flatbottomed microdilution culture plate. The antibiotic was 32 ,ug/ml for pristinamycin, >256 ,ug/ml for P1, and 32 ,ug/ml for P2. Results of susceptibility tests were the same in the dye uptake assay and the plaque assay, as previously reported (10) . The MICs of each antibiotic were the same for R. rickettsii and R. conorii. The MICs were 1 ,ug/ml for roxithromycin, 2 ,ug/ml for pristinamycin, >256 ,ug/ml for P1, and 2 ,ug/ml for P2. The toxic concentration of each drug except P1 was at least 16 times higher than the MIC; thus, toxicity for Vero cells did not interfere with the susceptibility tests. Pristinamycin results from the combination of two compounds, P1 and P2. P1 was ineffective against both rickettsial species, while the MIC of P2 was the same as that of pristinamycin, i.e., 2 ,xg/ml. There was no synergy of P1
and P2 against either species tested.
Discussion and conclusions. Chloramphenicol and tetracyclines are the recommended treatments for both RMSF and MSF. For both R. rickettsii and R. conorii, the MIC of chloramphenicol is 0.5 ,xg/ml, the MIC of doxycycline is 0.06 ,ug/ml, and the MIC of tetracycline is 0.25 ,ug/ml (10) . New quinolone compounds are also effective. The MICs of pefloxacin are 0.5 ,ug/ml for R. conorii and 1 ,ug/ml for R. rickettsii (9) . The MICs of ciprofloxacin are 0.25 ,ug/ml forR. conorii and 1 ,ug/ml for R. rickettsii (7) . Ciprofloxacin (6) , pefloxacin, and ofloxacin (1) have been successfully used in treating MSF. However, the toxicities of these effective antibiotics limit their use during pregnancy and childhood. Chloramphenicol causes aplastic anemia and gray syndrome in young children; tetracyclines given during pregnancy have teratogenic effects, and they stain the teeth yellow when given during childhood. The safety of new quinolone compounds for pregnant women is not ensured. Macrolide antibiotics have been proposed as alternative therapy in these situations. Erythromycin is effective in suppressing lethality for chicken embryos (11) , but its MICs are 4 ,ug/ml for R. conorii and 8 ,ug/ml for R. rickettsii, as determined by plaque assay (10) , and thus it is ineffective in humans. The superiority of tetracycline versus erythromycin in the treatment of MSF during childhood has been clearly established (5) . Spiramycin has MICs of 16 p.g/ml for R. conorii and 32 ,g/ml for R. rickettsii (8) The present work leads us to think that roxithromycin is effective, with a MIC of 1 ,ug/ml for both rickettsial species. These results confirm the heterogeneity of susceptibility of spotted-fever group rickettsiae to macrolide antibiotics; the reasons for this heterogeneity are not known. Each compound of this group must be tested in vitro to determine the susceptibilities of rickettsial strains. As for the streptogamin molecule, pristinamycin is effective in vitro against R. rickettsii and R. conorii. Prudent clinical trials must confirm the efficiency of roxithromycin and pristinamycin in the treatment of RMSF and MSF before they can be recommended for use during pregnancy and childhood.
